Navigation Links
GeneLink Reports 2011 Financial Results
Date:5/11/2012

and skin care products as a focus of its sales efforts.  With the added revenues anticipated from direct response and other targeted markets as well, we have high hopes for 2012."

Re-audit Required

In addition to its 2011 results, the Company reported that a re-audit of its 2010 financial statements resulted in a restatement of the Company's results for that year.

"While we are disappointed to have to restate our 2010 financial results, it's important to note that this restatement largely reflects a technical calculation regarding the beneficial conversion feature of our notes payable and had little impact on our previously reported 2010 revenues and operating loss and no net impact on 2010 cash flows," stated GeneLink's Chief Financial Officer, John A. Webb.

A re-audit of 2010 was required when, on March 5, 2012, the Company was notified that the Public Company Audit Oversight Board ("PCAOB") announced that it had suspended for one year the registration of Buckno Lisicky & Company, P.C. ("Buckno").  Buckno, the Company's prior independent registered accountants, was suspended for failure to timely file 2010 and 2011 annual reports with the PCAOB – a matter unrelated to its work with GeneLink. As a result of that suspension, the SEC determined that GeneLink could no longer include the audit reports of Buckno in its filings with them.  A re-audit by a new firm was required to address 2010 comparative figures included in the 2011 Form 10-K filing.

Additional information regarding the restatement will be included in a Form 8-K to be filed by the Company on or about May 11, 2012 with the U.S. Securities and Exchange Commission.

About GeneLink Biosciences, Inc.:

GeneLink Biosciences is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA test assessments linked to personalized health, beauty and wellness
'/>"/>

SOURCE GeneLink, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
2. GeneLink Reports First Quarter Gains
3. GeneLink Announces HelixLife Private Label Distribution Agreement
4. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
5. GeneLink Reports Third Quarter Results
6. GeneLink Announces New Licensing Partner
7. GeneLink Reports 2010 Results
8. GeneLink Reports Denial of Appeal
9. GeneLink Biosciences Expands its Scientific Advisory Board to Support New Product Lines
10. GeneLink Reports Second Quarter 2011 Results
11. GeneLink BioSciences, Inc. Ranked Number 33 Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 OTC ... Pharmaceuticals Inc., a biotechnology company, on its approval ... previously traded on OTCQX®, the best marketplace for ... Markets Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... the successful execution of its growth strategy and ...
(Date:8/21/2014)... 21, 2014 Ontotext S4 , ... Ontotext . Now the same enterprise hardened ... structured and unstructured data is available to start-ups and ... enterprise technology. Organizations that do not have resources to ... can use S4 since there is no need for ...
(Date:8/20/2014)... Clintrax Global, Inc., a worldwide provider ... Raleigh, NC , recently announced the addition ... of Administration. As Vice President ... including their alignment with company objectives and policies.  ... an HR executive, specializing in needs assessments, customer ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4Clintrax Global, Inc. Announces Addition to Executive Team 2Neurotrope To Host Conference Call 2
... Aug. 25 In celebration of a seminal discovery in ... the Philadelphia Chromosome Symposium: Past, Present and Future , ... at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia.  The ... first genetic abnormality associated with cancer, and the first to ...
... Scientists and engineers seek to meet three goals ... such as microalgae: efficiency, economical production and ecological ... of biomedical and chemical engineering in the L.C. ... SU chemical engineering Ph.D. student Satvik Wani have ...
... Inc. ("Dyadic") (Pink Sheets: DYAI ), ... development, manufacture and sale of specialty enzyme products ... biopharmaceutical industries, today announced that it has completed ... secured promissory notes (the "Notes") with two investors. ...
Cached Biology Technology:Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 2Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 3Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome 4SU research team uses nanobiotechnology-manipulated light particles to accelerate algae growth 2Dyadic International Raises $3 Million in Private Placement of Convertible Notes 2
(Date:8/20/2014)... /CNW/ -  Issue Serious allergic reactions ... life threatening for some children.    What you ... have food allergies and this number may be increasing, especially ... estimated to have food allergies.  The symptoms ... hives to breathing difficulties and loss of consciousness. Symptoms can ...
(Date:8/20/2014)... Oklahoma Medical Research Foundation a five-year, $14.5 million grant ... effects on humans. , For 10 years, OMRF ... the human immune response to anthrax bacteria as part ... funding came soon after anthrax-laced letters killed five and ... of Sept. 11, 2001. , The long-term goal ...
(Date:8/20/2014)... past few years, Virginia Tech,s Wu Feng has built ... from the "Computing in the Cloud" program, and synergistically ... million award from the Air Force on "big computing" ... and the National Institutes of Health on "big data" ... the "parallel computing" aspects from each grant, he was ...
Breaking Biology News(10 mins):Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3$14.5 million grant awarded to continue anthrax studies 2The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4
... analysis has found that both real and sham acupuncture treatments ... treat breast cancer. Published early online in CANCER , ... may help clinicians improve care for cancer patients. The results ... inert or may, like real acupuncture, have beneficial effects. ...
... new malaria treatments by identifying a way to stop malaria ... Chemistry , they show that blocking the activity of an ... mice from showing symptoms and extends their lifespan. The team ... and hope to start clinical trials of potential treatments within ...
... scientists have assumed that if mercury is high and increasing ... same is true of fish elsewhere in the Arctic. ... Canada has discovered that assumption is wrong in much of ... processes as a result of diverse atmospheric, geological, and biological ...
Cached Biology News:Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture 2Malaria drug target raises hopes for new treatments 2Virginia Tech research overturns assumption about mercury in the Arctic 2Virginia Tech research overturns assumption about mercury in the Arctic 3
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: